Title:
【発明の名称】トランスフォーミング増殖因子βによる末梢血における造血前駆細胞の増加
Document Type and Number:
Japanese Patent JPH09504516
Kind Code:
A
Abstract:
TGF beta is used to increase the numbers of stem cells in a subject's peripheral blood. Then the subject's blood is drawn and the stem cells removed. After myelosuppressive therapy is administered to the subject, the stem cells are administered to the subject. An alternate method provides for TGF beta administration to a donor subject whose blood is drawn and from whose blood the stem cells are removed; after a recipient subject receives myelosuppressive therapy, the stem cells are administered to the recipient subject.
Inventors:
Carlino, Joseph A.
Application Number:
JP50810995A
Publication Date:
May 06, 1997
Filing Date:
July 21, 1994
Export Citation:
Assignee:
Sertrics Pharmaceuticals, Inc.
International Classes:
A61K35/14; A61K35/28; A61K35/32; A61K35/55; A61K38/18; A61K38/27; A61K38/17; A61P7/00; (IPC1-7): A61K38/17; A61K38/27; A61K35/55; A61K35/32; A61K35/14
Attorney, Agent or Firm:
Shusaku Yamamoto